Shalini , K. (2024) “To Assess the Efficacy and Safety of Fixed-Dose Combination of Teneligliptin and Pioglitazone (Tiban P) in Iraqi Patients with Type 2 Diabetes Mellitus”, International Journal of Research in Pharmacy and Life Sciences, 12(02), pp. 31–37. doi:10.30904/j.ijrpls.2024.4722.